Summit Trail Advisors, LLC Abbott Laboratories Transaction History

Summit Trail Advisors, LLC

$3.97 Billion
Q3 2024

A detailed history of Summit Trail Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 28,035 shares of ABT stock, worth $3.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

28,035

Previous 20,231 38.57%

Holding current value

$3.3 Million

Previous $2.1 Million 52.05%

% of portfolio

0.08%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $780,946 - $921,886	7,804 Added 38.57%	28,035 $3.2 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $180,508 - $201,492	-1,792 Reduced 8.14%	20,231 $2.1 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $216,082 - $238,654	-1,973 Reduced 8.22%	22,023 $2.5 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $200,131 - $244,977	2,219 Added 10.19%	23,996 $2.64 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $268,248 - $321,852	-2,808 Reduced 11.42%	21,777 $2.11 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $1.33 Million - $1.48 Million	13,195 Added 115.85%	24,585 $2.68 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $224,327 - $264,047	2,316 Added 25.52%	11,390 $1.15 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $32,415 - $38,028	-341 Reduced 3.62%	9,074 $996,000
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $444,321 - $514,441	-4,592 Reduced 32.78%	9,415 $911,000
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $315,804 - $381,706	-3,094 Reduced 18.09%	14,007 $1.52 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $691,645 - $843,416	6,066 Added 54.97%	17,101 $2.02 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $1.27 Million - $1.56 Million	11,035 New	11,035 $1.55 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $329,070 - $358,592	-3,134 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $287,199 - $348,782	3,134 New	3,134 $352,000
Q1 2019 May 16, 2019	SELL	$66.22 - $80.06 $214,883 - $259,794	-3,245 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $497,010 - $563,040	-7,581 Reduced 70.03%	3,245 $235,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $658,329 - $794,195	10,826 New	10,826 $794,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $1.06 Million - $1.17 Million	-18,403 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$56.27 - $63.62 $42.2 Million - $47.8 Million	-750,650 Reduced 97.61%	18,403 $769,000
Q1 2018 May 21, 2018	BUY	$56.27 - $63.62 $42.4 Million - $47.9 Million	753,573 Added 4868.04%	769,053 $769,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $830,966 - $889,635	15,480	15,480 $938,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Abbott Laboratories Transaction History